Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECORD 2: Extended VTE prophylaxis with rivaroxaban vs enoxaparin after elective total hip replacement
2005-004691-20Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rivaroxaban in venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) (2 arms), sponsored by Bayer. Started Dec 2005; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on 2005-004691-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004691-20.